G-CSF-lentivirus administration in rats provided sustained elevated neutrophil counts and subsequent EPO-lentivirus administration increased hematocrits

Journal of Gene Medicine

Volumn 9, Issue 7, 2007, Pages 571-578

  Brzezinski, Margaret ^a   Yanay, Ofer ^a   Waldron, Lanaya ^a   Barry, Simon C ^a,b   Osborne, William R A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

EPO; G CSF; Gene therapy; Lentivirus; Neutropenia; Rats

Indexed keywords

COMPLEMENTARY DNA; ERYTHROPOIETIN; GENOMIC DNA; GRANULOCYTE COLONY STIMULATING FACTOR; LENTIVIRUS VECTOR; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE COUNT; ERYTHROPOIESIS; GENE EXPRESSION; HEMATOCRIT; LOW DRUG DOSE; LYMPHOCYTE COUNT; MALE; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PSEUDOTYPING; RAT; THROMBOCYTE COUNT; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; BLOOD CELL COUNT; DNA; ERYTHROPOIETIN; GENE THERAPY; GENOME; GRANULOCYTE COLONY-STIMULATING FACTOR; HELA CELLS; HEMATOCRIT; HUMANS; LENTIVIRUS; MALE; NEUTROPHILS; PROVIRUSES; RATS; RATS, INBRED F344;

ANIMALIA; LENTIVIRUS; RATTUS; VESICULAR STOMATITIS VIRUS;

EID: 34447568332     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1050     Document Type: Article

References (33)

1. Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003; 72: 82-93.
2. Dale DC, Hammond WP. Cyclic neutropenia: a clinical review. Blood Rev 1988; 2: 178-185.
3. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96: 2317-2322.
4. Horwitz M, Benson KF, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999; 23: 433-436.
5. Welte K, Boxer IA. Severe chronic neutropenia: pathophysiology and therapy. Semin. Hematol. 1997; 34: 267-268.
6. Zennou V, Petit C, Guetard D, et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000; 101: 173-185.
7. Follenzi A, Ailles LE, Bakovic S, et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000; 25: 217-222.
8. Charneau P, Clavel F. A single-strand gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J Virol 1991; 65: 2415-2421.
9. Zufferey R, Donello JE, Trono D, et al. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999; 73: 2886-2892.
10. Patzel V, Sczakiel G. The hepatitis B virus posttranscriptional regulatory element contains a highly stable RNA secondary structure. Biochem Biophys Res Commun. 1997; 231: 864-867.
11. Barry SC, Harder B, Brzezinski M, et al. Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression. Hum Gene Ther 2001; 12: 1103-1108.
12. Barry S, Brzezinski M, Yanay O, et al. Sustained elevation of neutrophils in rats induced by lentivirus-mediated G-CSF delivery. J Gene Med 2005; 7: 1510-1516.
13. Osborne WRA, Geary R, Lau S, et al. Transduced vascular smooth muscle cells in a canine model of gene therapy. Clin Res 1993; 41: 194A.
14. Seppen J, Barry SC, Harder B, et al. Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin. Blood 2001; 98: 594-596.
15. Wen D, Boissel J-PR, Tracy TE, et al. Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood 1993; 82: 1507-1516.
16. Soneoka Y, Cannon PM, Ramsdale EE, et al. A transient three-plasmid expression system for the production of high-titer retroviral vectors. Nucleic Acids Res 1995; 23: 628.
17. Seppen J, Barry SC, Klingspoor JH, et al. Apical gene transfer into quiescent human and canine polarized intestinal epithelial cells by lentiviral vectors. J Virol 2000; 74: 7642-7645.
18. Reiser J, Harmison G, Kluepfel-Stahl S, et al. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci USA 1996; 93: 15266-15271.
19. Mochizuki H, Schwartz JP, Tanaka K, et al. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 1998; 72: 8873-8883.
20. Zufferey R, Dull T, Mendal RJ, et al. Self-inactivating lentivirus vector for safe efficient in vivo gene delivery. J Virol 1998; 72: 9873-9880.
21. Yanay O, Brzezinski M, Christensen J, et al. An adult dog with cyclic neutropenia treated by lentivirus-mediated delivery of granulocyte colony-stimulating factor. Hum Gene Ther 2006; 17: 464-469.
22. Dale DC, Lau S, Nash R, et al. Effect of endotoxin on serum granulocyte and granulocyte-macrophage colony-stimulating factor levels in dogs. J Infect Dis 1992; 165: 689-694.
23. Lejnieks DV, Han SW, Ramesh N, et al. Granulocyte colony-stimulating factor expression from transduced vascular smooth muscle cells provides sustained neutrophil increases in rats. Hum Gene Ther 1996; 7: 1431-1436.
24. Seppen J, van Til NP, van der Rijt R, et al. Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats. 2005; 13: 672-677.
25. Muto S, Kawakubo M, Matsushita N, et al. Haematological data for Matsumoto Eosinophilic Shinshu rats as determined by an automated haematology analyser. Lab Anim 2005; 39: 122-129.
26. Hubert M-F, Laroque P, Gillet J-P, et al. The effects of diet, ad libitum feeding, and moderate and severe dietary restriction on body weight, survival, clinical pathology parameters, and cause of death in control Sprague-Dawley rats. Toxicol Sci 2000; 58: 195-207.
27. Kafri T, Blomer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997; 17: 314-317.
28. Abordo-Adesida E, Follenzi A, Barcia C, et al. Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther 2005; 16: 741-751.
29. Peng KW, Pham L, Ye H, et al. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther 2001; 8: 1456-1463.
30. VandenDriessche T, Thorrez L, Naldini L, et al. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 2002; 100: 813-822.
31. Yanay O, Barry SC, Katen LJ, et al. Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF delivery. Blood 2003; 102: 2046-2052.
32. Morstyn G, Dexter TM. Filgrastim (r-metHuG-CSF) in clinical practice. In Basic and Clinical Oncology, Cheson BD (ed). Marcel Dekker: New York, 1993; 351.
33. Rosenberg PS, Alter BP, Bolyard AA, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006; 107: 4628-4635.